Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional Results available

A Study of Ramucirumab (LY3009806) in Children With Refractory Solid Tumors

ClinicalTrials.gov ID: NCT02564198

Public ClinicalTrials.gov record NCT02564198. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 11:44 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1 Study Of Ramucirumab, a Human Monoclonal Antibody Against the Vascular Endothelial Growth Factor-2 (VEGFR-2) Receptor in Children With Refractory Solid Tumors, Including CNS Tumors

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main purpose of this study is to evaluate the safety of the study drug known as ramucirumab in children with recurrent or refractory solid tumors including central nervous system (CNS) tumors.

Study identification

NCT ID
NCT02564198
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
29 participants

Conditions and interventions

Eligibility (public fields only)

Age range
12 Months to 21 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 11, 2015 (Actual)
Primary completion
Jul 16, 2019 (Actual)
Completion
Jul 16, 2019 (Actual)
Last update posted
Aug 17, 2021

2015 – 2019

United States locations

U.S. sites
21
U.S. states
18
U.S. cities
21
Facility City State ZIP Site status
Childrens Hospital of Alabama Birmingham Alabama 35233 —
Children's Oncology Group Monrovia California 91016 —
Childrens Hospital of Orange County Orange California 92868 —
University of California, San Francisco San Francisco California 94158 —
Children's National Medical Center Washington D.C. District of Columbia 20010-2970 —
Children's Healthcare of Atlanta at Scottish Rite Atlanta Georgia 30322 —
Ann & Robert H Lurie Children's Hospital of Chicago Chicago Illinois 60611 —
Riley Hospital for Children Indianapolis Indiana 46202 —
Mark O Harfield-Warren Grant Magnuson Clinical Center Bethesda Maryland 20892 —
University of Michigan Health Systems Ann Arbor Michigan 48109 —
University of Minnesota Hospital Minneapolis Minnesota 55455 —
Washington University Medical School St Louis Missouri 63110 —
Columbia University Medical Center New York New York 10032 —
Children's Hospital Medical Center Cincinnati Ohio 45229-3039 —
Oregon Health and Science University Portland Oregon 97239 —
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104 —
Childrens Hospital of Pittsburgh Pittsburgh Pennsylvania 15224 —
St Jude Childrens Research Hospital Memphis Tennessee 38105 —
Texas Childrens Hospital Houston Texas 77030 —
Seattle Children's Hospital Research Foundation Seattle Washington 98105 —
Medical College of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02564198, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 17, 2021 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02564198 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →